1. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts: National Harbor, MD, USA. 9-13 November 2016. (8th December 2016) Authors: Althammer, Sonja; Steele, Keith; Rebelatto, Marlon; Tan, Tze Heng; Wiestler, Tobias; Schmidt, Guenter; Higgs, Brandon; Li, Xia; Shi, Li; Jin, Xiaoping; Antal, Joyce; Gupta, Ashok; Ranade, Koustubh; Binning, Gerd; Bellmunt, Joaquim; de Wit, Ronald; Vaughn, David J.; Fradet, Yves; Lee, Jae Lyun; Fo... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two: National Harbor, MD, USA. 9-13 November 2016. (16th November 2016) Authors: Ager, Casey; Reilley, Matthew; Nicholas, Courtney; Bartkowiak, Todd; Jaiswal, Ashvin; Curran, Michael; Albershardt, Tina C.; Bajaj, Anshika; Archer, Jacob F.; Reeves, Rebecca S.; Ngo, Lisa Y.; Berglund, Peter; ter Meulen, Jan; Denis, Caroline; Ghadially, Hormas; Arnoux, Thomas; Chanuc, Fabien; Fu... Journal: Journal for immunotherapy of cancer Issue: Volume 4(2016)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma. Issue 17 (6th May 2014) Authors: Hussain, Maha; Daignault, Stephanie; Agarwal, Neeraj; Grivas, Petros D.; Siefker‐Radtke, Arlene O.; Puzanov, Igor; MacVicar, Gary R.; Levine, Ellis Glenn; Srinivas, Sandy; Twardowski, Przemyslaw; Eisenberger, Mario A.; Quinn, David I.; Vaishampayan, Ulka N.; Yu, Evan Y.; Dawsey, Scott; Day, Kathl... Journal: Cancer Issue: Volume 120:Issue 17(2014) Page Start: 2684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. A randomized phase 2 trial of gemcitabine/cisplatin with or without cetuximab in patients with advanced urothelial carcinoma. Issue 17 (6th May 2014) Authors: Hussain, Maha; Daignault, Stephanie; Agarwal, Neeraj; Grivas, Petros D.; Siefker‐Radtke, Arlene O.; Puzanov, Igor; MacVicar, Gary R.; Levine, Ellis Glenn; Srinivas, Sandy; Twardowski, Przemyslaw; Eisenberger, Mario A.; Quinn, David I.; Vaishampayan, Ulka N.; Yu, Evan Y.; Dawsey, Scott; Day, Kathl... Journal: Cancer Issue: Volume 120:Issue 17(2014) Page Start: 2684 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. AXIN2 expression predicts prostate cancer recurrence and regulates invasion and tumor growth. Issue 6 (15th January 2016) Authors: Hu, Brian R.; Fairey, Adrian S.; Madhav, Anisha; Yang, Dongyun; Li, Meng; Groshen, Susan; Stephens, Craig; Kim, Philip H.; Virk, Navneet; Wang, Lina; Martin, Sue Ellen; Erho, Nicholas; Davicioni, Elai; Jenkins, Robert B.; Den, Robert B.; Xu, Tong; Xu, Yucheng; Gill, Inderbir S.; Quinn, David I.; ... Journal: Prostate Issue: Volume 76:Issue 6(2016) Page Start: 597 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Bevacizumab alone or in combination with TRC105 for patients with refractory metastatic renal cell cancer. Issue 23 (22nd August 2017) Authors: Dorff, Tanya B.; Longmate, Jeff A.; Pal, Sumanta K.; Stadler, Walter M.; Fishman, Mayer N.; Vaishampayan, Ulka N.; Rao, Amol; Pinksi, Jacek K.; Hu, James S.; Quinn, David I.; Lara, Primo N. Journal: Cancer Issue: Volume 123:Issue 23(2017) Page Start: 4566 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Circulating tumor cell telomerase activity as a prognostic marker for overall survival in SWOG 0421: A phase III metastatic castration resistant prostate cancer trial. Issue 8 (8th October 2014) Authors: Goldkorn, Amir; Ely, Benjamin; Tangen, Catherine M.; Tai, Yu‐Chong; Xu, Tong; Li, Hongli; Twardowski, Przemyslaw; Veldhuizen, Peter J. Van; Agarwal, Neeraj; Carducci, Michael A.; Monk, J. Paul; Garzotto, Mark; Mack, Philip C.; Lara, Primo; Higano, Celestia S.; Hussain, Maha; Vogelzang, Nicholas J... Journal: International journal of cancer Issue: Volume 136:Issue 8(2015:Apr. 15) Page Start: 1856 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Comparative effectiveness of screening strategies for colorectal cancer. Issue 9 (24th January 2017) Authors: Barzi, Afsaneh; Lenz, Heinz‐Josef; Quinn, David I.; Sadeghi, Sarmad Journal: Cancer Issue: Volume 123:Issue 9(2017) Page Start: 1516 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Eligibility Criteria and Endpoints in Metastatic Renal Cell Carcinoma Trials. (August 2020) Authors: Wong, Sarah E.; Quinn, David I.; Bjarnason, Georg A.; North, Scott A.; Sridhar, Srikala S. Journal: American journal of clinical oncology Issue: Volume 43:Number 8(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1/3 mRNA Expression. Issue 3 (14th October 2022) Authors: Sternberg, Cora N.; Petrylak, Daniel P.; Bellmunt, Joaquim; Nishiyama, Hiroyuki; Necchi, Andrea; Gurney, Howard; Lee, Jae-Lyun; van der Heijden, Michiel S.; Rosenbaum, Eli; Penel, Nicolas; Pang, See-Tong; Li, Jian-Ri; García del Muro, Xavier; Joly, Florence; Pápai, Zsuzsanna; Bao, Weichao; Elling... Journal: Journal of clinical oncology Issue: Volume 41:Issue 3(2023) Page Start: 629 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗